Xilio Therapeutics Balance Sheet (2020-2026) | XLO

Balance Sheet Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)
120.30M99.77M198.05M176.96M159.41M139.14M120.39M93.27M75.38M59.77M44.70M33.98M74.95M61.26M55.29M89.07M121.55M103.76M137.53M150.30M
Cash & Current Investments (Quarter)
120.30M99.77M198.05M176.96M159.41M139.14M120.39M93.27M75.38M59.77M44.70M33.98M74.95M61.26M55.29M89.07M121.55M103.76M137.53M150.30M
Receivables - Net (Quarter)
30.00M
Receivables (Quarter)
30.00M
Prepaid Assets (Quarter)
2.41M4.46M4.13M3.60M3.17M4.11M3.71M3.04M4.71M3.42M5.21M3.06M2.05M4.94M4.13M2.17M2.83M2.50M3.87M
Current Assets (Quarter)
105.57M202.52M181.09M163.01M142.31M124.50M96.98M78.42M64.48M48.13M69.19M78.01M63.31M60.23M93.20M123.72M124.09M145.03M154.21M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
7.11M7.62M7.47M7.44M7.55M7.25M7.25M6.80M6.37M5.94M5.54M5.14M4.84M4.47M4.29M4.02M3.68M3.89M3.68M
Other Non-Current Assets (Quarter)
1.55M1.55M1.55M1.55M0.34M1.56M0.27M0.23M1.57M1.58M1.59M0.12M1.77M1.77M1.78M1.79M1.79M1.80M1.81M1.81M
Non-Current Assets (Quarter)
15.15M15.54M15.27M15.12M15.10M14.67M14.53M13.93M13.36M12.80M13.42M11.87M11.35M10.84M10.52M10.10M9.61M9.66M9.28M
Assets (Quarter)
120.72M218.06M196.35M178.13M157.41M139.16M111.50M92.36M77.84M60.93M82.61M89.87M74.66M71.08M103.72M133.81M133.69M154.69M163.49M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
3.82M3.14M2.32M1.41M1.81M3.12M2.01M0.94M1.49M1.05M0.75M1.26M0.97M2.57M2.27M4.10M2.30M3.17M1.06M
Notes Payables (Quarter)
1.67M3.33M5.00M6.67M6.67M7.14M4.96M3.31M
Payables (Quarter)
3.82M3.14M3.99M4.74M6.81M9.79M8.68M8.09M6.44M4.37M0.75M1.26M0.97M2.57M2.27M4.10M2.30M3.17M1.06M
Accumulated Expenses (Quarter)
8.19M8.75M7.32M12.09M9.06M10.33M6.48M7.14M9.40M10.50M0.95M0.29M9.79M9.98M3.88M5.62M8.95M11.74M8.97M
Other Accumulated Expenses (Quarter)
0.29M0.32M0.19M0.08M0.26M0.08M0.08M0.08M0.17M0.05M0.03M0.13M0.14M0.13M0.17M0.20M0.09M0.08M0.20M
Current Leases (Quarter)
0.77M0.80M0.83M0.86M0.89M0.92M0.95M0.98M1.01M1.05M1.08M1.12M1.15M1.19M1.23M1.26M1.30M1.34M1.38M
Current Deferred Revenue (Quarter)
21.73M26.52M26.11M13.52M78.99M42.28M43.85M40.02M31.54M
Total Current Liabilities (Quarter)
12.87M12.78M12.22M17.77M16.84M21.12M16.19M16.29M16.93M15.96M31.58M38.64M38.02M27.26M47.64M53.26M56.40M56.27M42.96M
Non-Current Liabilities
Non-Current Debt (Quarter)
9.58M9.63M8.01M6.39M4.78M3.17M1.55M
Non-Current Deffered Revenue (Quarter)
17.40M10.25M8.40M19.26M38.74M28.63M25.50M20.64M16.47M
Preferred Stock Liabilities (Quarter)
7.31M100.15M
Operating Leases (Quarter)
10.32M10.11M9.89M9.66M9.43M9.19M8.95M8.68M8.41M8.14M7.86M7.57M7.26M6.95M6.64M6.30M5.96M5.61M5.25M
Other Non-Current Liabilities (Quarter)
1.52M0.12M0.10M0.08M0.06M0.04M0.03M0.01M38.55M53.93M29.56M26.26M
Total Non-Current Liabilities (Quarter)
32.77M32.51M30.13M33.83M31.05M33.47M26.69M24.98M88.19M87.86M89.85M64.68M
Total Liabilities (Quarter)
121.31M34.29M32.63M30.23M33.91M31.12M33.52M26.71M24.98M25.34M24.10M56.84M56.46M53.68M53.48M93.02M126.74M141.79M119.41M90.94M
Shareholder's Equity
Total Debt (Quarter)
9.58M9.63M8.01M6.39M4.78M3.17M1.55M
Common Equity (Quarter)
-121.31M-136.46M185.43M166.12M144.22M126.30M105.65M84.79M67.38M52.50M36.83M25.77M33.42M20.97M17.60M10.70M7.07M-8.10M35.27M72.55M
Shareholder's Equity (Quarter)
-121.31M-136.46M185.43M166.12M144.22M126.30M105.65M84.79M67.38M52.50M36.83M25.77M33.42M20.97M17.60M10.70M7.07M-8.10M35.27M72.55M
Liabilities and Shareholders Equity (Quarter)
120.72M218.06M196.35M178.13M157.41M139.16M111.50M92.36M77.84M60.93M82.61M89.87M74.66M71.08M103.72M133.81M133.69M154.69M163.49M
Retained Earnings (Quarter)
-141.19M-160.89M-182.24M-206.85M-226.64M-249.11M-271.75M-291.10M-307.90M-325.51M-342.70M-356.60M-370.70M-383.75M-397.02M-412.86M-429.15M-418.79M-428.32M
Treasury Shares (Quarter)
0.14M0.11M0.10M0.08M0.06M0.05M0.03M0.02M0.01M0.01M0.48M0.45M0.45M0.03M0.33M0.33M0.33M0.02M0.02M